Healthcare -
Biotechnology - NASDAQ - US
$ 4.58
0 %
$ 12.5 M
Market Cap
-0.25
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Axcella Health Inc.
| Net Income | -81.2 M |
| Depreciation & Amortization | 412 K |
| Capital Expenditures | -426 K |
| Stock-Based Compensation | 3.58 M |
| Change in Working Capital | 3.16 M |
| Others | 7.22 M |
| Free Cash Flow | -70 M |
Cash Flow
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | ||||||
| Net Income | (81.2) | (64.6) | (56.5) | (59.0) | (36.1) | (30.9) |
| Depreciation & Amortization | 0.4 | 0.3 | 0.4 | 0.7 | 1.1 | 1.4 |
| Deferred Income Tax | 0 | 0 | 0 | 33 K | 22 K | (0.3) |
| Stock Based Compensation | 3.6 | 6.2 | 6.3 | 5.8 | 2.8 | 1.2 |
| Other Operating Activities | 4.4 | 1.5 | 0.7 | 0.6 | 0.5 | 0.5 |
| Change in Working Capital | 3.2 | 2.3 | (0.7) | 1.0 | 1.0 | 1.2 |
| Cash From Operations | (69.6) | (54.2) | (49.8) | (51.0) | (30.7) | (26.9) |
| INVESTING CASH FLOW | ||||||
| Capital Expenditures | (0.4) | (0.3) | (0.2) | (0.1) | (0.7) | (1.1) |
| Other Items | 31.3 | 3.3 | (35.9) | 19 K | 73 K | 0.2 |
| Cash From Investing Activities | 30.9 | 3.0 | (36.1) | (0.1) | (0.6) | (0.9) |
| FINANCING CASH FLOW | ||||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 32.2 | 3.2 | 65.4 | 63.7 | 63.9 | 25.7 |
| Cash From Financing Activities | 32.2 | 3.2 | 65.4 | 63.7 | 63.9 | 25.7 |
| CHANGE IN CASH | ||||||
| Net Change In Cash | (6.4) | (48.0) | (20.5) | 12.6 | 32.6 | (2.1) |
| FREE CASH FLOW | ||||||
| Free Cash Flow | (70.0) | (54.5) | (50.0) | (51.1) | (31.4) | (28.0) |